1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 30 NOVEMBER 2015

Cancer Drug News 30 NOVEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Early Adoption Of Open Innovation To Set Companies Apart
Industry Brief - Sunesis Granted European Patent Covering Qinprezo
Industry Brief - CHMP Recommends Oncaspar For ALL In Combination Therapy
Industry Brief - EC Conditionally Approves Blincyto For Ph- ALL
Industry Brief - CTI Initiates Rolling NDA Submission For Pacritinib In MF
Industry Brief - EC Approves Expanded Label For Xalkori
Industry Brief - Aduro's CRS-207 Gains EU Orphan Designation For MPM
Industry Brief - First Patient Dosed In Tipifarnib Phase II Trial
Industry Trend Analysis - Vaccine Rollout Programmes Will Prove To Be Challenging
Industry Brief - Elplat Indication Expanded In Japan
Industry Brief - XBiotech Reveals Xilonix Phase III CRC Trial Irregularities
Industry Brief - EC Approves Cotellic/Zelboraf Combination For Advanced Melanoma
Industry Trend Analysis - Aduro Entering A Defining Period
Industry Brief - Cellceutix' Kevetrin Gains FDA ODD For Retinoblastoma
Industry Brief - Opdivo Expands Indications In US/Aligns EU Brandname
Industry Trend Analysis - SSA Cancer Burden Driving Diagnostic Demand

Table Of Contents

Cancer Drug News 30 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.